Form 8-K - Current report:
SEC Accession No. 0001640334-25-002118
Filing Date
2025-11-14
Accepted
2025-11-14 16:07:43
Documents
15
Period of Report
2025-11-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 25935
2 AMENDMENT TO BYLAWS artl_ex31.htm EX-3.1 3112
  Complete submission text file 0001640334-25-002118.txt   151047

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA artl-20251110.xsd EX-101.SCH 5022
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20251110_lab.xml EX-101.LAB 15735
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20251110_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20251110_pre.xml EX-101.PRE 9993
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20251110_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 4146
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 251485996
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)